Bluebird bio Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
3.71
0.02
(0.54%)
Volume:
120,816
52 week range:
3.56 - 28.60
Market Cap:
36.321M
Company Description:
bluebird bio, Inc., researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc.